ARCHIVES

FDA Approves Rituxan For NHL With CHOP Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 2 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

BMS Demands Resignation Of Two ImClone Executives

February 8, 2002

Cooper, Frederickson Formally Named To Top Health, NIH Positions

April 25, 1975

Gene Therapy Hyped By Scientists, Panel Tells NIH; Emphasis Must Be Basic Research

December 15, 1995

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

January 25, 2008

NCI Advisory Group, Other Cancer Meetings for Oct., Nov., Future

September 29, 1989

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

April 16, 2004